ARTICLE | Strategy
Medco and Repligen face the future
July 17, 1995 7:00 AM UTC
Medco Research Inc. shareholders who opposed the terms of the proposed merger with Repligen Corp. got their wish, with the deal foundering last week after the companies couldn't reach a new deal.
The issue now is whether MRE shareholders have traded long-term growth for short-term profits. For RGEN shareholders, the issue is how the company will continue to restructure for survival...